Clinical trials: Hemodialysis Patients
Renal Failure Chronic Requiring Hemodialysis
Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients
The investigators propose that pharmacist interventions would reduce the amount of unresolved medication-related problems in hemodialysis patients.
- Trial name
- NCT01356563
- Testing
- pharmaceutical care
- Where
- 2 sites in Taiwan
- Volunteers
- 150 people
- Sponsor
- Sin-Lau Hospital
Hemodialysis
Physical Activity Prescription Program for Hemodialysis Patients
The goal of this clinical trial is to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in…
- Trial name
- Move More (NCT06830993)
- Testing
- "Move More" Personalized Exercise Program, Intradialytic Exercise Program
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of Arizona
End Stage Renal Disease
Effect of Educution in Control Nutrition and Fluid Control of Hemodialysis Patient
Hemodialysis patients are required to adhere to diet and fluid restriction. The literature shows that hemodialysis patients have low adherence to diet and fluid restriction.
- Trial name
- RCT (NCT05682508)
- Testing
- Education group
- Where
- Turkey (Türkiye)
- Volunteers
- 62 people
- Sponsor
- Ege University
Hemodialysis Patients
Effects of Physical Activity on the Microcirculation in Hemodialysis Patients
Chronic kidney disease (CKD) is associated with high level of peripheral arterial disease (PAD). This could lead wounds, infections then amputations or deaths by impairment of the peripheral cutaneous perfusion.
- Trial name
- ACTIVDIAL (NCT01866891)
- Testing
- Three months of regular perdialytic physical activity (cycling)
- Where
- France
- Volunteers
- 27 people
- Sponsor
- Hospices Civils de Lyon
Renal Failure Chronic Requiring Hemodialysis, Poor Quality Sleep
BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients
Based on many previous data proving hypervolemia in chronic hemodialysis patients could lead to sleep apnea and poor sleep quality.
- Trial name
- BEDTIME (NCT02825589)
- Testing
- BIA
- Where
- Thailand
- Volunteers
- 19 people
- Sponsor
- Mahidol University
Hemodialysis Patients, Peripheral Vascular Disease
Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
Peripheral arterial disease (PAD) is the most common manifestation of systemic atherosclerosis and accounts for significant morbidity and mortality among end-stage renal disease (ESRD) patients.
- Trial name
- NCT00431249
- Testing
- Cilostazol
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Tungs' Taichung Metroharbour Hospital
Haemodialysis Complication
Cooler Dialysis and Liver Perfusion and Function
Having hemodialysis affects the blood supply to various organs in the body including the heart and the brain. With time, these effects build up and can affect the way these organs function.
- Trial name
- NCT02997774
- Testing
- Cooler dialysis, Standard Dialysis
- Where
- Canada
- Volunteers
- 16 people
- Sponsor
- Chris McIntyre
Hemodialyzed Patients, Epoetin Treatment
Epoetin Dosing Regimens in Haemodialysis
Currently, less frequent than once weekly subcutaneous epoetin administration regimens were shown to be equally effective and safe as the once-weekly schedules in stable pre-dialyzed and peritoneal dialyzed patients…
- Trial name
- NCT00349960
- Testing
- NeoRecormon SC once-weekly versus once-every-other-week
- Where
- 9 sites in Romania
- Volunteers
- 200 people
- Sponsor
- Romanian Society of Nephrology
Chronic Kidney Diseases
Transitioning to Home or In-center Dialysis
For people with advanced kidney disease, deciding which type of dialysis is best can be challenging. Studies have shown that quality of life is very important to patients.
- Trial name
- TRANSIT-CARE (NCT05989659)
- Testing
- Exposure: Home dialysis or facility-hemodialysis
- Where
- Canada
- Volunteers
- 420 people
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
End Stage Renal Disease
Triferic Pediatric Pharmacokinetic Protocol
The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered intravenously in pediatric patients with chronic kidney disease on chronic hemodialysis (CKD-5HD).
- Trial name
- NCT02595437
- Testing
- Triferic
- Where
- 9 sites in United States
- Volunteers
- 22 people
- Sponsor
- Rockwell Medical Technologies, Inc.
Anemia of Chronic Kidney Disease
Clinical Validation of the Management Process for Renal Anemia in Maintenance Hemodialysis Patients
This test aims to verify that the management process of renal anemia in maintenance hemodialysis patients can improve the hemoglobin compliance rate better than that of anemia management by primary doctors, and promote the system…
- Trial name
- NCT06463236
- Testing
- Guiding treatment, empirical therapy
- Where
- China
- Volunteers
- 1,296 people
- Sponsor
- Hong Daqing
End Stage Renal Disease
Pilot Study of Taste Sensations in Patients With End-stage Renal Disease on Hemodialysis
Individuals on dialysis due to kidney failure have very prescriptive diets. These diets help increase dialysis effectiveness and help patients control blood levels of electrolytes including potassium and phosphate, acid-base…
- Trial name
- NCT03495271
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- Purdue University
Myelodysplastic Syndrome, Myelofibrosis
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
In transfusion-dependent myelodysplastic syndromes patients, regular blood transfusions lead to iron overload, which can cause organ damage, hormonal imbalances, and increased infection risk, ultimately impacting patient…
- Trial name
- MEXIRON (NCT06781099)
- Testing
- Low-volume continuous veno-venous haemodialysis with MEX-CD1 use
- Where
- 2 sites in France
- Volunteers
- 13 people
- Sponsor
- Hospices Civils de Lyon
Pruritus
A Study of SHR0410 in Hemodialysis Patients With Pruritus
The aim of this study is to evaluate the safety, tolerability and pharmacokinetics of SHR0410 in hemodialysis patients with moderate to severe pruritus
- Trial name
- NCT04317209
- Testing
- SHR0410
- Where
- China
- Volunteers
- 54 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
End Stage Renal Disease
Trace Element Replenishment Study in Hemodialysis Patients
A pilot randomized trial that compares a new renal nutritional supplement with the standard renal vitamin. The primary objective is to compare two doses (medium and high) of the new supplement with the renal vitamin currently…
- Trial name
- NCT01473914
- Testing
- Low dose: supplemental zinc, selenium and vitamin E, Standard renal vitamin: B and C renal vitamin, Medium dose: supplemental zinc, selenium and vitamin E
- Where
- 2 sites in Canada
- Volunteers
- 150 people
- Sponsor
- Marcello Tonelli
End-Stage Renal Disease
Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)
This study evaluates the effect of a single cognitive-behavioral intervention (CBI) in a control group against the same CBI plus the strengthening of resiliency skills in an experimental group, on ESRD patients.
- Trial name
- ESRD (NCT03330938)
- Testing
- CBI and Resilience, Cognitive-behavioral Intervention
- Where
- Mexico
- Volunteers
- 50 people
- Sponsor
- Hospital Civil de Guadalajara
End Stage Renal Disease on Dialysis
Compare Elbow mNT-BBAVF With Wrist RCAVF for Hemodialysis Access
Investigator plan to conduct a multicenter, open-labelled, randomized study to compare the primary patency and safety of elbow mNT-BBAVF and wrist RCAVF in hemodialysis patients.
- Trial name
- NCT03701243
- Testing
- mNT-BBAVF, RCAVF
- Where
- China
- Volunteers
- 160 people
- Sponsor
- Shanghai 10th People's Hospital
Chronic Hemodialysis Patients, Caregivers of Chronic Hemodialysis Patients
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
Background: The preventive containment measures implemented in the COVID-19 pandemic are not feasible in chronic hemodialysis patients (HD) who need to attend their dialysis sessions 3 times a week.
- Trial name
- SeroCOVIDial (NCT04420338)
- Testing
- Blood sample, Serum tube collection
- Where
- France
- Volunteers
- 800 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
End Stage Renal Disease on Dialysis
Colchicine and Inflammation in Hemodialysis Patients
Chronic, low-grade inflammation is regarded as a common comorbid condition in chronic dialysis patients. Increased inflammatory markers in chronic dialysis patients are associated with adverse clinical outcomes .
- Trial name
- CICI-HP (NCT05677555)
- Testing
- Colchicine 0.5 MG
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Assaf-Harofeh Medical Center
End Stage Renal Disease
The 2-minute Walk Test in Hemodialysis Patients
Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to…
- Trial name
- NCT06650215
- Where
- Turkey (Türkiye)
- Volunteers
- 36 people
- Sponsor
- Kirsehir Ahi Evran Universitesi
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.